Yan Leyfman?linkedIn
Oct 19, 2025, 11:19
Yan Leyfman: Insightful Strategies Advancing the Safety and Precision of Myeloma Care
Yan Leyfman, Co-Founder and Executive Director of MedNews Week, shared a post on LinkedIn:
“Exceptional presentation by global multiple myeloma cell therapy leader Dr. Adriana Rossi (Icahn School of Medicine at Mount Sinai) on managing T-cell–directed toxicities at the 2025 Lymphoma, Leukemia & Myeloma Congress!
Insightful strategies advancing the safety and precision of myeloma care.”
Stay updated with Hemostasis Today.
-
Mar 6, 2026, 16:51Priya Reehal: Highlighting The Central Role of Nurses in Cardio-Oncology
-
Mar 6, 2026, 16:50Rainer Kaiser: Blinatumomab Shows Remarkable Response in Multi-Refractory ITP and APS
-
Mar 6, 2026, 16:18Laila Shalabi: Clopidogrel, Aspirin, and the Role of PPIs in Coronary Artery Disease
-
Mar 6, 2026, 16:17Paul McKenzie: The Value of Gene Therapy in Bleeding Disorders
-
Mar 6, 2026, 16:15Basma El Homasany: The ‘Little Brain’ of the Heart and Its Role in Health
-
Mar 6, 2026, 16:14Jamal Rana: Family History and Polygenic Risk for Coronary Heart Disease
-
Mar 6, 2026, 15:43Kristy Ainslie: Breaking Down the Discovery and FDA Approval of Drug Carriers
-
Mar 6, 2026, 15:18Claudio Laudani: Efficacy and Safety of Colchicine for Secondary Prevention in Coronary Artery Disease
-
Mar 6, 2026, 15:09Chris Simon: Persona PLUS Receives FDA Clearance for Patent‑Protected Plasma Apheresis